Open access
321
Views
27
CrossRef citations to date
0
Altmetric
Review
Profile of neratinib and its potential in the treatment of breast cancer
Katharina Feldinger1 Department of Oncology, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford
& Anthony Kong2 The Robert Aitkin Institute, School of Cancer Sciences, University of Birmingham, Birmingham, UKCorrespondence[email protected]
Pages 147-162
|
Published online: 09 Jun 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.